Bullous pemphigoid is a subepidermal autoimmune blistering disease associated with autoantibodies to the hemidesmosomal bullous pemphigoid antigens 180 and 230. Most sera from bullous pemphigoid patients recognize epitopes within the N-terminal NC16A portion of the bullous pemphigoid 180 ectodomain. Using cryosections of human skin, patients' sera were shown to generate dermal±epidermal separation when coincubated with leukocytes and complement from healthy volunteers; however, the speci®city of pathogenic autoantibodies in bullous pemphigoid patients has not yet been elucidated. In this study, by the use of a modi®ed version of the cryosection model, we show that sera from all of 13 bullous pemphigoid patients and from two rabbits, immunized against bullous pemphigoid 180 NC16A, induced dermal±epidermal separation. This ®nding was con®rmed with the use of IgG puri®ed from patients' sera, whereas sera and puri®ed IgG from healthy controls were not pathogenic. The induction of subepidermal splits in this experimental model was shown to be dependent on the presence of neutrophils, but not complement. Interestingly, patients' autoantibodies af®nity puri®ed against a recombinant form of bullous pemphigoid 180 NC16A retained their blister-inducing capacity, whereas patients' IgG depleted of reactivity to NC16A lost this ability. F(ab¢) 2 fragments of antibodies speci®c to NC16A, lacking the Fc portion, did not induce splits. In addition, patients' autoantibodies puri®ed against a recombinant fragment of the C-terminus of bullous pemphigoid 180 as well as rabbit antibodies to the intracellular portion of bullous pemphigoid 180 and to bullous pemphigoid 230 did not cause dermal±epidermal separation. Our in vitro results support the idea that autoantibodies to bullous pemphigoid 180 from patients with bullous pemphigoid are of pathogenic relevance. Key words: autoantigen/autoimmunity/collagen/dermal±epidermal junction/hemidesmosome. J Invest Dermatol 118: 664±671, 2002 B ullous pemphigoid (BP) is a subepidermal autoimmune blistering disease of the elderly characterized by tissuebound and circulating autoantibodies to the dermal± epidermal junction (DEJ) (Schmidt and Zillikens, 2000) . Autoantibodies in BP are directed to two hemidesmosomal components, including BP230, an intracellular constituent of the hemidesmosomal plaque (Stanley et al, 1981 (Stanley et al, , 1988 , and the transmembrane protein BP180 (Labib et al, 1986; Diaz et al, 1990; Giudice et al, 1992) . The majority of BP sera react with epitopes clustered within the 16th noncollagenous (NC16A) domain of BP180 (Giudice et al, 1993; Zillikens et al, 1997b) and serum levels of autoantibodies to BP180 NC16A were shown to parallel disease activity in patients with this disease (Schmidt et al, 2000a) .
The pathogenic effect of rabbit antibodies generated against the murine homolog of BP180 NC16A has previously been demonstrated in a passive transfer mouse model of BP (Liu et al, 1993) . In addition, the functional relevance of autoantibodies from patients with BP was recently shown when cultured human keratinocytes, incubated with IgG from BP patients triggered a signal transduction event that led to the expression and secretion of interleukins 6 and 8 (Schmidt et al, 2000b) ; however, the blister-inducing capacity of human autoantibodies to BP180 has not yet been unequivocally demonstrated. Gammon et al (1982a) have previously shown that serum samples from patients with BP induce dermal±epidermal separation (DES) in cryosections of human skin when incubated with leukocytes and complement from healthy donors; however, at the time this experimental model was developed, tools to characterize the speci®city of pathogenically relevant autoantibodies in patients' sera were not available. In this study, we show that IgG antibodies to human BP180, puri®ed from sera of BP patients and from rabbits immunized against recombinant human BP180, induce DES in cryosections of human skin. This effect was shown to be mediated by binding of autoantibodies to the NC16A domain of human BP180.
by direct immuno¯uorescence (IF) microscopy; (iv) circulating IgG autoantibodies that ®xed complement to the epidermal side of 1 M NaCl-split human skin by indirect IF microscopy; and (v) reactivity to BP180 NC16A as detected by immunoblot analysis and enzyme-linked immunosorbent assay. Findings in patients' sera by indirect IF microscopy on 1 M NaCl-split skin, reactivity with BP180, BP230, and LAD-1 (as analyzed by immunoblotting of keratinocyte extracts, conditioned concentrated HaCaT medium, and a recombinant form of the BP180 C-terminus), and enzyme-linked immunosorbent assay reactivity against recombinant BP180 NC16A are shown in Table I .
Polyclonal rabbit antibodies to BP180 and BP230 Two rabbit sera, R2296 and SA8010, were raised against a glutathione-S-transferase fusion protein containing a 42 amino acid stretch of human BP180 NC16A (NC16A2±4). Preimmune and anti-GST rabbit serum (Sigma, St Louis, MO) were used as controls. Rabbit serum SA6760 was generated against a fusion protein spanning amino acids 61±360 of the intracellular domain of BP180 (Scha Ècke et al, 1998) . Rabbit serum to BP230 was generated against a 165 kDa recombinant fragment of the C-terminal domain of BP230 (Tanaka et al, 1990) . The characteristics of these antibodies are shown in Table II .
Preparation of cryosections, indirect IF microscopy, and complement-®xation test Neonatal human foreskin, obtained from routine circumcision, was washed in cold phosphate-buffered (PBS), cut in pieces of 5 Q 15 mm, embedded in optimum cutting temperature compound (Sakura Finetek Europe BV, Zoeterwonde, the Netherlands), and stored at ±80°C. Four cryosections of 6 mm were placed in the center of a Superfrost Plus microscope slide (Menzel-Gla Èser, Braunschweig, Germany) (Gammon et al, 1982) . Indirect IF microscopy on 1 M NaCl-split human skin followed a previous protocol (Zillikens et al, 1996) . The complement-®xation test was performed on cryosections of human skin (Katz et al, 1976) . Bound C3 was visualized using a¯uorescein isothiocyanate-labeled goat anti-human C3 antibody (Kallestad Diagnostics, Austin, TX). For antigen mapping studies, mouse monoclonal antibodies to human type IV collagen (clone CIV 22, Sigma), laminin 5 (clone GB3, Loughborough Leicestershire, U.K), and BP230 (1E5; Hirako et al, 1998) were used.
Af®nity puri®cation of total IgG and IgG speci®c for epitopes on BP180 IgG from serum samples of patients, rabbits, and controls was isolated using protein G sepharose fast¯ow af®nity column chromatography (Pharmacia AB, Uppsala, Sweden) as reported (Schmidt et al, 2000b) . Antibodies to BP180 were af®nity puri®ed from sera of BP patients and immunized rabbits using an AminoLink Plus immobilization kit following the manufacturer's instructions (Pierce, Rockford, IL). Brie¯y, recombinant GST fusion proteins containing the NC16A2±4 segment or a cocktail of fusion proteins containing NC16A1, NC16A1± 3, and NC16A2±5 fragments (ratio 1:1:3) were covalently coupled to 4% beaded agarose at pH 10. Similarly, the GST-BP180 4575 representing a recombinant form of the C-terminus of BP180 was immobilized on the agarose matrix. Serum samples were incubated with peptide loaded matrix; antibodies were eluted with 0.1 M glycine buffer (pH 2.5) and neutralized with Tris±HCl. Eluted antibodies were concentrated under extensive washing with PBS (pH 7.2) using Ultrafree 15 ®lters (Millipore, Bradford, MA). After immunoaf®nity puri®cation against NC16A, total IgG of the¯ow-through was puri®ed using protein G. Reactivity of¯ow-through and eluted fractions was analyzed by indirect IF microscopy on salt-split skin and by immunoblotting of recombinant NC16A, GST-BP180 4575 and both full-length and soluble (LAD-1) keratinocyte-derived BP180. F(ab¢) 2 fragments of autoantibodies to BP180 NC16A were prepared using a standard protocol (Parham, 1983) . The completeness of fragmentation and the reactivity of the F(ab¢) 2 preparations was tested by indirect IF microscopy on 1 M salt split-skin using¯uorescein isothiocyanate-labeled secondary antibodies speci®c to Fab (Sigma) and Fc (Serotec Ltd, Oxford, U.K.) portions of IgG, respectively.
Production of recombinant and cell-derived forms of BP180 GST fusion proteins containing full-length BP180 NC16A (NC16A1±5) (Fig 1) , various fragments of this domain, including NC16A1, NC16A3, NC16A2±4, NC16A2±5, and the BP180 4575 C-terminal segment (Balding et al, 1996) , were expressed in Escherichia coli DH5a (Zillikens et al, 1997b) . Fusion proteins were puri®ed by glutathione agarose af®nity chromatography (Giudice et al, 1993) . The soluble ectodomain of BP180 (LAD-1) and full-length BP180 were prepared from cultured keratinocytes (Zillikens et al, 1999) . Immunoblotting and enzyme-linked immunosorbent assay using BP180 NC16A were performed as described (Zillikens et al, 1997a,b) .
Peripheral blood leukocytes and complement Peripheral blood leukocytes from healthy volunteers were isolated by a sedimentation gradient containing sodium diatrizoate and dextran 500 following the instructions of the manufacturer (Nycomed, Oslo, Norway). Cells were harvested, washed twice in RPMI 1640 (Life Technologies, Karlsruhe, Germany) and resuspended in the same medium at a density of 6 Q 10 7 cells per ml. The cell suspension was kept on ice and cell viability was tested using trypan blue; preparations with a viability greater than 95% were used. Serum samples from healthy volunteers served as a source of human complement (Gammon et al, 1980) and were diluted 2-fold with RPMI.
Treatment of cryostat sections Sera from BP patients and controls were heat inactivated for 30 min at 56°C and diluted 5-fold in PBS. Protein G af®nity puri®ed IgG was diluted in PBS resulting in a ®nal Titer of indirect immuno¯uorescence microscopy on 1 M NaCl-split human skin.
b
Linear deposits of human C3 at the DEJ demonstrated by complement-®xation test. VOL. 118, NO. 4 APRIL 2002 concentration of 4 mg per ml. Rabbit antibodies to BP180 and BP230 were used at an indirect IF titer of 320. Cryostat sections were washed with PBS for 5 min to remove embedding medium before incubation with 50 ml of diluted sera or antibody preparations for 90 min at room temperature. After washing the sections with PBS twice, chambers were prepared as described elsewhere (Gammon et al, 1982a) with minor modi®cations. Brie¯y, tissue containing slides were covered with a second slide to which transparent adhesive tape (Beiersdorf AG, Hamburg, Germany) had been placed around each end. The tape prevented contact of the skin sections with the covering slide thus creating a chamber of approximately 0.3 mm in thickness and a volume of 0.5 ml. Both slides were taped together and the leukocyte suspension, mixed 1:1 with either diluted fresh or heated serum or medium alone, was injected into the chambers. Chambers were incubated in a humidi®ed air incubator containing 5% CO 2 (Memmert, Schwabach, Germany) for 3 h at 37°C. Subsequently, chambers were disassembled and sections were washed in PBS for 10 min to remove excess serum and nonadherent cells, air dried for 10 min, ®xed in formalin, and ®nally stained with hematoxylin and eosin. Sections were examined by two blinded independent investigators at Q50, Q100, and Q200 magni®ca-tions. As criterion for DES we set the presence of more than three areas of separation at the DEJ with more than 40 mm in length.
RESULTS
Sera and puri®ed IgG from BP patients recruit neutrophils to the DEJ and induce subepidermal splits in cryosections of human skin Serum samples from BP patients (n = 13) labeled the DEJ when incubated with cryosections of human skin (Fig 2a) , whereas sera from healthy controls (n = 13) showed no binding (Fig 2d) . Incubation of cryosections with serum samples from BP patients, followed by incubation with complement-containing serum and leukocytes from healthy volunteers, led to the attachment of neutrophils to the DEJ, and most importantly, to the induction of subepidermal splits by all of the 13 BP sera (Fig 2b; Table III ). In contrast, sera from healthy controls did not induce leukocyte attachment to the DEJ or a subepidermal split (Fig 2e) . When the serum as a source of complement was heat inactivated or omitted completely, BP sera still induced subepidermal splits (Fig 2c) . Omitting complement, neutrophil attachment to the stratum corneum, induced by both patients' and control sera, was abolished (Fig 2c, f ) . Using protein G af®nity puri®ed IgG from four BP patients (Table V) and four healthy volunteers, we observed the same ®ndings compared with the use of whole serum. IgG from BP patients, in contrast to controls, led to neutrophil attachment and induced subepidermal cleavage. No separation occurred when leukocytes were omitted.
The extent of neutrophil attachment to the DEJ depends on both the concentration of antibodies to BP180 and the incubation time with the cells In a further set of experiments, we investigated the time dependency of neutrophil attachment to the DEJ incubating the cryosections with three different BP sera (BP-SA, BP-CE, and BP-HU) for 1, 2, 3, and 4 h, respectively. Leukocyte attachment to the DEJ was strongest after an incubation time of 1 h and declined subsequently, whereas the extent of DES increased after an incubation time of 1 h and reached its maximum after 3 h (Fig 3) . To study the dependency of leukocyte attachment on levels of autoantibodies to BP180 NC16A, we puri®ed antibodies speci®c to NC16A from two BP patients (BP-CE and BP-SA) by immunoaf®nity chromatography. Higher concentrations of antibodies to NC16A induced stronger leukocyte attachment compared with incubation with preparations containing less reactivity to NC16A (Table IV) . Splits induced experimentally by autoantibodies from BP patients localize to the lamina lucida of the DEJ To study the level of split formation, we stained cryosections, that had previously been incubated with sera from BP patients and leukocytes, with monoclonal antibodies to human BP230 (1E5), type IV collagen, and laminin 5. Antibodies to BP230 stained the roof of the split, whereas those to both type IV collagen and laminin 5 labeled the dermal side demonstrating that the level of split formation localizes to the lamina lucida of the DEJ.
Immunoadsorption against recombinant BP180 NC16A abolishes the capacity of BP patients' sera to induce DES Sera from two BP patients (BP-SA and BP-CE) were subjected to af®nity puri®cation using a cocktail of recombinant fragments covering the entire NC16A domain of BP180 that was covalently coupled to an agarose matrix. Total IgG from¯ow-through fractions was isolated by protein G chromatography and concentrated to the same volume as the eluted fraction. The eluted IgG strongly reacted with recombinant NC16A by immunoblot analysis. In contrast, IgG from¯ow-through fractions showed no reactivity with NC16A demonstrating the complete elimination of antibodies to this portion of BP180 (Fig 4) . Subsequently, IgG speci®c for BP180 NC16A and¯ow-through fractions were tested by indirect IF microscopy on 1 M NaCl-split skin. Interestingly, both eluted and¯ow-through fractions still contained IgG that bound to the epidermal side of the split (Table V) . When concentrated to the same volume, indirect IF titers of¯ow-through fractions were 2-fold lower compared with the eluted fractions. Both eluted and¯ow-through fractions also reacted with cellderived full-length BP180 and LAD-1 (Fig 4) indicating that the immunoadsorption procedure only abolished antibodies to NC16A from the sera, whereas IgG directed to other autoantigens or to other portions of the BP180 molecule remained unaffected. Importantly, IgG speci®c to the NC16A domain of BP180 induced subepidermal splits in the cryosections (Fig 5c) , whereas the¯ow-through fractions of BP sera lost their blister-inducing capacity (Fig 5d) . When we concentrated the IgG from¯ow-through fractions to an indirect IF titer 2-fold higher compared with the eluted fraction, these preparations still did not induce leukocyte attachment to the DEJ or subepidermal cleavage. Under these conditions, the IgG concentration of the¯ow fraction was 80-fold (BP-SA) and 280-fold (BP-CE) higher, respectively, compared with the eluted fraction and the IgG preparations had the same complement-®xing ability. In a further set of experiments, we puri®ed antibodies speci®c to the C-terminus of BP180 from serum of three BP patients (BP-CE, BP-SA, and BP-PR) using Figure 3 . Attachment of leukocytes to the DEJ is strongest after short incubation times, whereas DES is more extensive with longer incubation. In the upper panel, cryosections were incubated with serum from BP-SA followed by incubation with leukocytes for 1, 2, and 3 h, respectively. Scale bar: 40 mm. The lower panel shows the extent of leukocyte attachment and DES after incubating the cryosections with three BP sera (BP-SA, BP-CE, and BP-HU). The mean values of percent of the total length of DEJ with attached leukocytes (r) or DES (j) are demonstrated at incubation times of 1, 2, 3, and 4 h, respectively. The individual readings with the three different sera are also shown (leukocyte attachment, s; DES, +). Antibodies speci®c to NC16A were isolated from the serum of two patients (BP-SA, BP-CE) by immunoaf®nity column chromatography and incubated with cryosections of human skin followed by a 2 h incubation with human leukocytes. Titer of antibodies puri®ed against BP180 NC16A by indirect IF microscopy on 1 M NaCl-split human skin.
c Length of DEJ with attached leukocytes in relation to total length (percent). VOL. 118, NO. 4 APRIL 2002 recombinant GST-BP180 4575. Antibody preparations to this fragment of BP180, which strongly ®xed complement, were concentrated to a titer of 80 (Table V) . While at this titer, patient antibodies speci®c to NC16A induced DES, antibodies speci®c to the BP180 C-terminus induced no leukocyte attachment and no DES.
F(ab¢) 2 fragments of autoantibodies to NC16A do not induce subepidermal cleavage in cryosections of human skin To address the question, if the Fc portion of autoantibodies is of importance for blister induction in our in vitro model, we prepared F(ab¢) 2 fragments of antibodies that had been eluted from NC16A coupled to agarose. IgG speci®c to NC16A from two BP patients (BP-SA and BP-CE) was digested with pepsin. F(ab¢) 2 fragments, lacking the Fc portion of the antibody, were used at the same indirect IF titer (80) as the original unfragmented antibody preparations to BP180 NC16A that were pathogenic; however, F(ab¢) 2 preparations did not induce subepidermal cleavage when incubated with the cryosections.
IgG from rabbits immunized against recombinant human BP180 NC16A induce subepidermal splits in skin cryosections For this study, we immunized two rabbits (R2296 and SA8010) against recombinant NC16A2±4. When cryosections Figure 4 . Immunoblot analysis using IgG from BP sera af®nity puri®ed against BP180 NC16A Puri®cation of autoantibodies to BP180 NC16A1±5 from two BP sera (BP-SA and BP-CE) was performed using an agarose beaded gel covalently coupled with a cocktail consisting of NC16A1, NC16A1±3, and NC16A2±5 encompassing the entire NC16A domain. Left panel, immunoblotting of recombinant BP180 NC16A with BP-SA (lanes 1±3) and BP-CE (lanes 4±6). IgG autoantibodies eluted from the column (lanes 3 and 6) react, like reference control serum BP-CO (lane 7), with NC16A, whereas¯ow-through fractions (lanes 2 and 5) or normal serum (lane 8) show no reactivity. Right panel, Immunoblotting of keratinocyte-derived fulllength BP180. Serum samples from BP-SA and BP-CE (lanes 1 and 4) , eluted fractions (lanes 3 and 6), but also IgG in¯ow-through fractions (lanes 2 and 5) react with full-length BP180 (arrow). Reactivity of control sera (BP-CO and NHS) is shown in lanes 7 and 8. Migration position of molecular weight markers are depicted on the left and right. Total IgG fractions were isolated from human sera using protein G af®nity column chromatography (stock preparations). Concentrations of af®nity puri®ed antibodies were determined using Bradford protein assay. Antibodies to BP180 NC16A from patients' and rabbit sera were af®nity puri®ed against recombinant NC16A fragments covalently coupled to an agarose matrix.
e Antibodies to C-terminal BP180 from patients' sera were af®nity puri®ed against the recombinant 4575 fragment covalently coupled to an agarose matrix. EF, eluted fraction; FTF,¯ow-through fraction.
were incubated with sera SA8010 and R2296 or with IgG from SA8010, af®nity puri®ed against BP180 NC16A2±4, and subsequently treated with leukocytes from healthy donors, a subepidermal split formation was observed (Fig 5a) . In contrast, preimmune rabbit sera, serum from a rabbit immunized against recombinant GST, and the¯ow-through fraction of serum SA8010, obtained after subjecting the serum to af®nity puri®cation with recombinant NC16A2±4, did not bind to the DEJ and did not induce DES in the cryosections (Fig 5b) . Although used at the same indirect IF titers as rabbit antibodies to NC16A (320), rabbit antibody SA6760 to the intracellular domain of BP180 and a rabbit antibody to BP230 were not pathogenic in this model.
DISCUSSION
In this study, we show the capacity of antibodies to human BP180 from patients with BP and from rabbits immunized with recombinant BP180 to induce subepidermal splits. This study used, with some modi®cations, an in vitro model originally described by Gammon et al (1982a) involving cryosections of human skin, sera from BP patients, and leukocytes; however, at the time their model was ®rst reported, the different speci®cities of autoantibodies in BP sera had not been elucidated. Subsequent work demonstrated that autoantibodies in BP sera are directed to two major autoantigens, BP180 and BP230 (Stanley et al, 1981 (Stanley et al, , 1988 Labib et al, 1986; Diaz et al, 1990) . Previous attempts to induce BP by passive transfer of patients' autoantibodies into different animals had failed (Sams and Gleich, 1971; Gammon and Briggaman, 1988) . The pathogenic relevance of BP180 was strongly suggested by the use of an animal model where neonatal mice injected with rabbit anti-murine BP180 antibodies developed a BP-like subepidermal blistering disease (Liu et al, 1993) ; however, the pathogenic effect of antibodies to BP180 from patients with BP has not been demonstrated to date. Recently, we also failed to induce blisters by injection of autoantibodies to BP180 from patients with BP into human skin grafted on to severe combined immunode®cient mice (Zillikens et al, 2001) .
In this study, we therefore used the cryosection model to test the hypothesis that antibodies to human BP180 are pathogenic. In a ®rst set of experiments, we reproduced the ®nding of Gammon et al (1982a) that sera from BP patients induce subepidermal splits in cryosections of human skin. Subsequently, this observation was con®rmed with the use of IgG fractions isolated by protein G af®nity puri®cation from BP patients, whereas normal human sera or normal IgG caused no DES. The level of experimentally induced split formation localizes to the lamina lucida of the DEJ, the same site where blister formation occurs in the patient's skin (Schmidt and Zillikens, 2000) . Interestingly, omission of complement did not change the extent of DES in our assay. Gammon et al (1982a) had also found some degree of DES in cryosections treated with heatinactivated serum. Their three-step skin chamber method consisted of incubation with BP sera (step 1), followed by leukocytes (step 2), and ®nally by fresh serum as a source of complement (step 3). Importantly, in their assay, the incubation with leukocytes was performed prior to the addition of complement. In addition, to remove nonadherent leukocytes the sections were then rinsed in PBS before complement was added. This sequence of incubation steps could not undoubtedly clarify the role of complement for the induction of splits in the assay described by Gammon et al (1982a) ; however, from these and our own data one may not conclude that complement activation is not essential for blister formation in BP. In the cryosection model, in contrast to the in vivo situation, the leukocytes do not have to migrate along a chemotactic gradient from blood vessels to the DEJ. Instead, by incubating the cryosections with leukocytes, the cells are placed in close contact with the DEJ. As in the cryosection model there is no requirement for complement to induce splits, the role of complement in blister formation of human BP cannot be explored in this in vitro model and will be addressed in future studies using other experimental models. On the other hand, our data clearly show the importance of neutrophils for the induction of DES in the cryosection model: (i) omitting leukocytes resulted in a lack of split formation, and (ii) pepsin digestion of split-inducing autoantibodies, which leads to a loss of the Fc portion (mediating binding of neutrophils to immune complexes), also abolished split formation.
In a second set of our experiments, we studied the timedependency of leukocyte attachment and split formation in our assay. We demonstrate that leukocyte attachment to the DEJ predominates over DES with shorter incubation times (1 h) and declines with longer incubation, whereas the extent of DES increases gradually and reaches its maximum with longer incubation (3 h). When fresh serum was added as a source of complement, we regularly found attachment of neutrophils to the stratum corneum of the cryosections irrespective of whether the sections were incubated with sera/puri®ed IgG from patients or controls. This observation is in line with the ®nding that corneocytes may activate the alternative complement pathway thus mediating the adhesion of leukocytes to serum-treated stratum corneum in an antibody-independent manner (Terui et al, 1989; Terui et al, 1995) . When fresh serum was omitted or replaced by heat-inactivated serum, we did not observe a major neutrophil adhesion to the stratum corneum.
The importance of antibodies to the NC16A domain of BP180 has been suggested by several lines of evidence: (i) in experimental murine BP, antibodies to the murine homolog of human NC16A induce skin blisters in neonatal mice (Liu et al, 1993 (Liu et al, , 1995 ; (ii) in BP patients, serum levels of circulating antibodies to NC16A, in contrast to indirect IF microscopy titers of antibodies to the DEJ, correlate with disease activity (Schmidt et al, 2000a); and (iii) antibodies to the NC16A domain were identi®ed to trigger expression and secretion of in¯ammatory mediators when incubated with cultured normal human keratinocytes (Schmidt et al, 2000b) . In a further set of experiments, we therefore tested the pathogenic relevance of antibodies to BP180 NC16A from BP patients in cryosections of human skin. Interestingly, when we af®nity puri®ed antibodies speci®c to BP180 NC16A from the serum of BP patients, this fraction induced a concentrationdependent leukocyte attachment to the DEJ, and subsequently subepidermal splits in the cryosections. The split-inducing potential of autoantibodies speci®c to BP180 NC16A was shown to be dependent on their Fc portion. In contrast, serum fractions that were depleted of reactivity BP180 NC16A (¯ow-through fractions) lost their split-inducing capacity, although they remained reactive with full-length BP180 and LAD-1 derived from cultured keratinocytes. Autoantibodies from BP patients, puri®ed against the C-terminus of BP180, and used at the same indirect IF titer and IgG concentration as antibodies to NC16A, were also not pathogenic. These data suggest that the split-inducing ability of autoantibodies is associated with their speci®city. This is further supported by ®ndings using the experimental mouse model of BP. By molecular mapping studies it was shown that the blisterinducing ability of rabbit antibodies generated to different recombinant forms of murine BP180 was dependent on their ®ne speci®city (Liu et al, 1995) . Evidence that speci®city of antibodies may be associated with their pathogenicity is also provided by studies using a mouse model for hemolytic anemia where mice develop autoantibodies to different membrane antigens on erythrocytes. An analysis of autoantibodies and of a panel of antired blood cell monoclonal antibodies derived from the diseased mice revealed that pathogenic and nonpathogenic autoantibodies differed with regard to their speci®city (DeHeer et al, 1978; Shibata et al, 1990; Diiulio et al, 1997) . In these mice, anemia was shown to be mediated by Fc receptor-dependent erythrophagocytosis (Shibata et al, 1990; Clynes and Ravetch, 1995) .
In a ®nal set of experiments, the pathogenic relevance of antibodies to the NC16A domain was further con®rmed by the ®nding that treatment of cryosections of human skin with rabbit sera generated against BP180 NC16A2±4 also resulted in subepidermal splits. No split was induced when rabbit serum was depleted of reactivity against NC16A2±4 by af®nity chromatography or when cryosections were incubated with preimmune rabbit sera. Interestingly, although used at the same indirect IF titers as rabbit antibodies to NC16A, rabbit antibodies to the intracellular domain of BP180 did not induce subepidermal splits when incubated with the cryosections, nor did rabbit antibodies to BP230.
In summary, this study demonstrates that antibodies to human BP180, in the presence of leukocytes, induce subepidermal splits in cryosections of human skin, which con®rms that BP180 plays a key part in the pathogenesis of BP. We show that the pathogenic mechanisms that lead to subepidermal split formation are mediated by autoantibodies targeting epitopes within the NC16A domain of BP180. Future studies will be aimed at characterizing the pathogenically relevant epitope(s) within NC16A and other potentially relevant epitopes on the BP180 molecule.
